Slower degradation rate of cytarabine in blood samples from acute myeloid leukemia by comparison with control samples

Slower degradation rate of cytarabine in blood samples from acute myeloid leukemia by comparison with control samples


Only units of this product remain
DOI 10.1007/s00280-020-04150-9